Collagen Solutions PLC Conference attendance
March 01 2018 - 1:02AM
RNS Non-Regulatory
TIDMCOS
Collagen Solutions PLC
01 March 2018
1 March 2018
Collagen Solutions to Present at Canaccord Genuity
Musculoskeletal Conference &
Exhibit at American Academy of Orthopaedic Surgeons
Conference
Dates: 6-9 March 2018
Collagen Solutions Plc (AIM: COS), (the "Company"), the
developer and manufacturer of medical grade collagen and tissue
components for use in regenerative medicine, including orthopaedic,
dental, wound care, and cardiovascular applications, confirms two
forthcoming conferences it will be attending in New Orleans,
Louisiana, USA, between 6-9 March 2018.
-- Jamal Rushdy, CEO, to present at the Canaccord Genuity Musculoskeletal Conference (6 March)
-- Company to Exhibit at the American Academy of Orthopaedic
Surgeons "AAOS" Annual Conference (7-9 March)
AAOS is the world's largest and most prestigious annual
orthopaedic meeting so attending this conference and presenting at
the accompanying Canaccord Genuity Musculoskeletal Conference
provides access to an extremely wide range of investors and
manufacturers in areas of spine, trauma/extremities, foot and
ankle, and sports medicine.
Commenting on the conferences, Jamal Rushdy, CEO said: "We are
pleased to have the opportunity to present at the Canaccord Genuity
Musculoskeletal Conference, where we will highlight our recently
announced positive 8-year follow-on data from ChondroMimetic(R)
demonstrating durable cartilage regeneration in keyhole knee
surgery. We are also excited to be a first-time exhibitor at AAOS
and to showcase our OEM capabilities and propriety device licensing
opportunities to investors and industry partners. These meetings
provide the opportunity to actively engage with orthopaedic
companies on a global scale. We will also be providing hands-on
demonstrations of prototypes for our Bone Graft Substitute,
ChondroMimetic(R) Cartilage Repair Scaffold, and Fibrillar Collagen
development programmes."
Collagen Solutions Plc Tel: +44 (0) 141 648 9100
Jamal Rushdy, Chief Executive Officer
Hilary Spence, Chief Financial Officer
Lisa Baderoon, Head of Investor Relations Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com
Cenkos Securities plc (NOMAD and Broker) Tel: +44 (0) 207 397 8900
Stephen Keys
Steve Cox
Walbrook PR Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: +44 (0) 7876 741 001
Helen Cresswell
About Collagen Solutions:
Collagen Solutions Plc is a global supplier, developer, and
manufacturer of medical grade collagen, tissues, and related
medical devices and components for use in regenerative medicine,
medical devices and in-vitro diagnostics and research. The Company
is also expanding its range of biomaterials-based finished medical
devices based on its internal and acquired intellectual property
for commercialisation with partners via licensing and distribution
arrangements, including ChondroMimetic(R). The Company's products
are used in a wide variety of applications including orthopaedics,
cardiovascular, dental, plastic surgery, wound healing, neurology
and urology.
For more information go to: www.collagensolutions.com
The American Academy of Orthopedic Surgeons (AAOS)
AAOS is an orthopedic organisation. Founded at Northwestern
University in 1933, as of 2015 AAOS had grown to include about
39,000 members. The group provides education and practice
management services for orthopedic surgeons and allied health
professionals. The AAOS also lobbies and works on public education.
The AAOS describes itself as "the world's largest medical
association of musculoskeletal specialists.
For more information go to: www.aaos.org
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAZMGZZNRFGRZM
(END) Dow Jones Newswires
March 01, 2018 02:02 ET (07:02 GMT)
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Dec 2024 to Jan 2025
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jan 2024 to Jan 2025